Severe Acute Respiratory Syndrome

Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus, called SARS-associated coronavirus (SARS-CoV). SARS was first reported in Asia in February 2003. Over the next few months, the illness spread to more than two dozen countries in North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was contained.

SARS or Severe Acute Respiratory Syndrome is a viral respiratory illness caused by a coronavirus - the SARS associated coronavirus (SARS-CoV) - which can be life-threatening.

How SARS is Spread

SARS, Treatment, Control and Tests

SARS: Tips for Travellers

SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses

SARS-CoV-2 disrupts cholesterol metabolism by using its ORF3a protein to sequester cholesterol in lysosomes, reducing BMP levels and optimizing viral survival. This novel mechanism offers insights into long-term metabolic complications of COVID-19.

19 Nov 2024

Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients

The ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not meeting statistical significance.

18 Nov 2024

Futuristic AI-powered virtual lab designs potent SARS-CoV-2 nanobodies

AI-human collaboration in a "Virtual Lab" successfully designs and experimentally validates nanobodies with enhanced binding to SARS-CoV-2 variants, offering a novel approach to interdisciplinary research.

14 Nov 2024

HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities

Research on HEPA-14 air purifiers in aged care reveals no significant impact on respiratory infections, though initial phase results suggest potential benefits.

13 Nov 2024

Inequities in COVID-19 vaccination coverage for older adults highlighted in global study

Researchers provide a global overview of COVID-19 vaccination programs among the elderly.

13 Nov 2024

Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17

Research indicates the Pfizer-BioNTech vaccine effectively reduces MIS-C incidence in children, supporting vaccination as a critical public health measure.

12 Nov 2024

Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes

Research shows prenatal exposure to SARS-CoV-2 linked to slight regulatory behavior improvements in infants, but no significant neurodevelopmental impacts.

12 Nov 2024

Link between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disorders

COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, necessitating continued health vigilance.

8 Nov 2024

WHO study names top pathogens in need of new vaccines

A new World Health Organization (WHO) study published today in eBioMedicine names 17 pathogens that regularly cause diseases in communities as top priorities for new vaccine development.

5 Nov 2024

For kids and teens, extra weight could mean a higher chance of long COVID

The study reveals a dose-response relationship between BMI and PASC risk in children, highlighting obesity as a key factor in post-COVID health challenges.

30 Oct 2024

Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients

Nirmatrelvir-ritonavir effectively lowers hospitalization rates and long COVID symptoms in non-hospitalized, high-risk patients with mild to moderate COVID-19.

30 Oct 2024

One in four healthy young Marines report long-term physical, cognitive, or psychiatric effects after mild COVID-19

Researchers examine the long-term health effects of SARS-CoV-2 infection in a cohort of United States Marines.

29 Oct 2024

Masks and smart seating cut COVID-19 risks on flights, review finds

Air travel review reveals sporadic SARS-CoV-2 transmission, with mask use and seating proximity key to infection risk.

24 Oct 2024

Genetic risk factors for long-COVID uncovered in a large multi-ethnic study

Researchers identified genetic loci and phenotypes linked to long-COVID in the largest multi-ethnic GWAS, revealing increased risk factors for chronic conditions like fatigue, depression, and fibromyalgia.

16 Oct 2024

COVID-19 raises the risk of type 2 diabetes in children, study reveals

Researchers found that children who contracted COVID-19 were at a higher risk of developing type 2 diabetes within six months, compared to those with other respiratory infections.

15 Oct 2024

Study shows no developmental delays in toddlers post-COVID-19 infection

Study explored the relationship between SARS-CoV-2 infection in children under two years old and cognitive development, finding no evidence of increased developmental delays post-infection. Differences in socioeconomic status were noted between COVID-19 positive and negative groups.

15 Oct 2024

The long-term cardiac impact of COVID-19

Study shows that severe COVID-19 elevates the long-term risk of major adverse cardiac events (MACE), making it comparable to coronary artery disease. It also highlights a genetic interaction with ABO blood type, influencing cardiovascular outcomes.

13 Oct 2024

COVID-19 significantly raises stroke risk

Researchers conducted a metaumbrella review of 34 systematic reviews and 70 studies, uncovering a significant link between COVID-19 severity and increased stroke risk. The review emphasizes the need for further investigation into underlying mechanisms and potential biases.

9 Oct 2024

COVID-19 increases chronic fatigue risk

Study reveals that COVID-19 significantly increases the risk of chronic fatigue syndrome, with specific populations, such as older adults, Asians, and non-hospitalized patients, at higher risk.

7 Oct 2024

Study reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypes

Study found that influenza vaccination is highly effective in preventing infection and hospitalization in children, though efficacy against certain subtypes like H3N2 remains limited due to small sample sizes.

6 Oct 2024

Severe Acute Respiratory Syndrome

Overview

How SARS is Spread

SARS, Treatment, Control and Tests

SARS: Tips for Travellers

Latest Severe Acute Respiratory Syndrome News and Research

SARS-CoV-2 hijacks cholesterol trafficking to fuel infection and evade immune responses

Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients

Futuristic AI-powered virtual lab designs potent SARS-CoV-2 nanobodies

HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities

Inequities in COVID-19 vaccination coverage for older adults highlighted in global study

Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17

Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes

Link between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disorders

WHO study names top pathogens in need of new vaccines

For kids and teens, extra weight could mean a higher chance of long COVID

Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients

One in four healthy young Marines report long-term physical, cognitive, or psychiatric effects after mild COVID-19

Masks and smart seating cut COVID-19 risks on flights, review finds

Genetic risk factors for long-COVID uncovered in a large multi-ethnic study

COVID-19 raises the risk of type 2 diabetes in children, study reveals

Study shows no developmental delays in toddlers post-COVID-19 infection

The long-term cardiac impact of COVID-19

COVID-19 significantly raises stroke risk

COVID-19 increases chronic fatigue risk

Study reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome

Overview

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in